Soligenix, Inc.

The momentum for this stock is not very good. Soligenix, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Soligenix, Inc..

Soligenix, Inc. engages in the development and commercialization of products to treat rare disease....

News

Soligenix Receives European Patent for Improved Production of Synthetic Hypericin

PR Newswire Soligenix Receives European Patent for Improved Production of Synthetic Hypericin Soligenix Receives European Patent for Improved Production of Synthetic Hypericin PR Newswire PRINCETON, N.J., Sept...\n more…

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire ORLANDO, FL / ACCESSWIRE / August 16, 2024 / RedChip Companies will air interviews with Soligenix Inc. (Nasdaq:SNGX) and American Resources Corp. (Nasdaq:AREC) on the RedChip Small Stocks, Big...\n more…

Soligenix Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St Soligenix ( NASDAQ:SNGX ) Second Quarter 2024 Results Key Financial Results Net loss: US$1.64m (loss widened by 2.0...\n more…

Soligenix reports Q2 EPS ($1.31) vs ($3.56) last year

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results

PR Newswire Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results PR Newswire PRINCETON, N.J...\n more…